Monitoring Induction Therapy & MRD in Multiple Myeloma

Opinion
Video

Caitlin Costello, MD, shares insights on the role of minimal residual disease (MRD) assessment in the multiple myeloma treatment process, including its impact on induction therapy and disease monitoring.

Recent Videos
4 experts are featured in this series.
3 experts in this video
3 experts in this video
3 experts in this video
3 experts in this video
Using bispecific antibodies before or after CAR T-cell therapy in multiple myeloma is an area of education for community oncologists.
3 experts in this video
3 experts in this video
2 experts are featured in this series.
9 Experts are featured in this series.
Related Content